phaidra.vetmeduni.ac.at o:1747 DOI 10.1002/clt2.12097 Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey The COVID-19 pandemic has affected health care systems unexpectedly. However, data focusing on practical considerations experienced by health care professionals (HCPs) providing care to allergic patients is scarce.Under the framework of the European Academy of Allergy and Clinical Immunology (EAACI), a panel of experts in the field of immunotherapy developed a 42-question online survey, to evaluate real-life consequences of the COVID-19 pandemic in allergy practice.The respondents in the survey were 618. About 80% of HCPs indicated being significantly affected in their allergy practice. A face-to-face visit reduction was reported by 93% of HCPs and about a quarter completely interrupted diagnostic challenges. Patients with severe uncontrolled asthma (59%) and anaphylaxis (47%) were prioritized for in-person care. About 81% maintained an unaltered prescription of inhaled corticosteroids (ICS) in asthmatics. About 90% did not modify intranasal corticosteroids (INCS) in patients with allergic rhinitis. Nearly half of respondents kept biological prescriptions unmodified for asthma. About 50% of respondents kept their allergen immunotherapy (AIT) prescription patterns unchanged for respiratory allergies; 60% for insect venom allergies. Oral immunotherapy (OIT) for food allergies was initiated by 27%. About 20% kept carrying out up-dosing without modifications and 14% changed to more prolonged intervals. Telemedicine practice was increased.HCPs providing care to allergic patients were affected during the pandemic in diagnostic, management, and therapeutic approaches, including AIT for respiratory, insect-venom, and food allergies. Most HCPs maintained controller treatments for both asthma, and allergic rhinitis consistent with international recommendations, as well as biological agents in asthma. Remote tools are valuable in delivering allergy care. eng allergen-immuntherapie; allergie; biologika; COVID-19; umfrage 2023-06-20T12:57:17.581Z LOMv1.0 Author BEGIN:VCARD VERSION:3.0 N:Alvaro-Lozano;Montserrat; FN:Montserrat Alvaro-Lozano X-ORCID:https://orcid.org/0000-0002-5528-8043 END:VCARD BEGIN:VCARD VERSION:3.0 N:Pfaar;Oliver; FN:Oliver Pfaar X-ORCID:https://orcid.org/0000-0003-4374-9639 END:VCARD BEGIN:VCARD VERSION:3.0 N:Bonini;Mateo; FN:Mateo Bonini END:VCARD BEGIN:VCARD VERSION:3.0 N:Untersmayr;Eva; FN:Eva Untersmayr END:VCARD BEGIN:VCARD VERSION:3.0 N:Sturm;Gunter; FN:Gunter Sturm X-ORCID:https://orcid.org/0000-0002-7245-121X END:VCARD BEGIN:VCARD VERSION:3.0 N:Brough;Helen; FN:Helen Brough X-ORCID:https://orcid.org/0000-0001-7203-0813 END:VCARD BEGIN:VCARD VERSION:3.0 N:Klimek;Ludger; FN:Ludger Klimek X-ORCID:https://orcid.org/0000-0002-2455-0192 END:VCARD BEGIN:VCARD VERSION:3.0 N:Heffler;Enrico; FN:Enrico Heffler X-ORCID:https://orcid.org/0000-0002-0492-5663 END:VCARD BEGIN:VCARD VERSION:3.0 N:Chaker;Adam; FN:Adam Chaker END:VCARD BEGIN:VCARD VERSION:3.0 N:Quecchia;Cristina; FN:Cristina Quecchia END:VCARD BEGIN:VCARD VERSION:3.0 N:Tomic Spiric;Vesna; FN:Vesna Tomic Spiric END:VCARD BEGIN:VCARD VERSION:3.0 N:Sahiner;Umit; FN:Umit Sahiner X-ORCID:https://orcid.org/0000-0003-0088-913X END:VCARD BEGIN:VCARD VERSION:3.0 N:Jensen-Jarolim;Erika; FN:Erika Jensen-Jarolim X-ORCID:https://orcid.org/0000-0003-4019-5765 END:VCARD BEGIN:VCARD VERSION:3.0 N:Giovannini;Mattia; FN:Mattia Giovannini X-ORCID:https://orcid.org/0000-0001-9568-6882 END:VCARD BEGIN:VCARD VERSION:3.0 N:Sandoval-Ruballos;Mónica; FN:Mónica Sandoval-Ruballos X-ORCID:https://orcid.org/0000-0002-8747-4799 END:VCARD https://w3id.org/kim/hcrt/scheme https://w3id.org/kim/hcrt/text Textdokument Text LOMv1.0 yes https://creativecommons.org/licenses/by/4.0 application/pdf 711179 https://phaidra.vetmeduni.ac.at/o:1747 https://phaidra.vetmeduni.ac.at/api/object/o:1747/thumbnail LOMv1.0 discipline